生物製藥塑膠市場規模、佔有率和成長分析：按產品類型、材料、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球生物製藥塑膠市場價值為 225.2 億美元，預計到 2033 年將從 2025 年的 241.9 億美元成長至 428.5 億美元，預測期（2026-2033 年）複合年成長率為 7.42%。

全球生物製藥塑膠市場正經歷顯著成長，這主要得益於對一次性系統日益成長的需求，這些系統能夠提升生產柔軟性並降低污染風險。藥物研發、生物製藥生產和臨床供應等關鍵應用越來越依賴聚合物組件，這些組件對於確保無菌性、擴充性和法規合規性至關重要——而這些對於產品安全和上市準備都至關重要。從不銹鋼轉向一次性系統正在降低資本支出並加速產能擴張。此外，對敏捷供應鏈和嚴格污染控制的需求正迫使製造商採用經過驗證的一次性產品，從而簡化流程並減輕文件負擔。諸如一次性生物反應器系統和預填充聚合物注射器等創新產品表明，材料技術的進步和供應商能力的提升正在為該領域創造巨大的成長機會並降低成本。

全球生物製藥塑膠市場促進因素

全球生物製藥塑膠市場的主要驅動力是嚴格的監管要求和安全標準，這些要求和標準要求在生物製藥生產中使用高品質的聚合物材料。這些材料對於最大限度地降低污染風險和確保生產過程的完整性至關重要。因此，市場對專為檢驗的性能要求的無菌一次性系統而設計的特種塑膠的需求激增。這種需求促使製造商擴展產品線並加強品質保證措施。注重合規性有助於建立長期夥伴關係，並促進採用專門設計的組件。最終，透過使生產實踐與監管預期保持一致並顯著降低生產變異性，從而推動行業成長。

全球生物製藥塑膠市場限制因素

由於材料相容性問題，特別是與洗脫劑和萃取劑的相容性問題，全球生物製藥塑膠市場面臨嚴峻挑戰。因此，生物製藥開發商往往極為謹慎，阻礙了創新聚合物配方在關鍵生產流程中的應用。由於需要進行全面的相容性測試和表徵，企業通常更傾向於使用成熟的材料，而非潛在的更優替代品。這種規避風險的做法不僅使生物製藥產品的開發複雜化，也延長了供應商和材料的認證流程，最終影響市場發展。

生物製藥塑膠的全球市場趨勢

全球生物製藥塑膠市場正呈現一次性系統快速擴張的顯著趨勢，這主要得益於其能夠提升生產效率和安全性。隨著生物製程日趨靈活且可擴展，這些系統在加速生產進度的同時，也能降低交叉污染的風險。製造商和契約製造機構 (CMO) 越來越傾向於客製化聚合物組件、連接器和無菌零件，以實現快速切換，而無需大量前期投資。這一趨勢促進了塑膠供應商和終端用戶之間的合​​作開發，從而建立了一個多元化、一體化的供應鏈，該供應鏈強調可靠性以及與自動化系統的無縫相容性。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球生物製藥塑膠市場規模：依產品類型分類

• 免洗袋子
• 生物製程容器
• 管材和連接器
• 瓶子和管瓶

全球生物製藥塑膠市場規模：依材料分類

• 聚乙烯（PE）
• 聚丙烯（PP）
• 乙烯-醋酸乙烯酯共聚物（EVA）

全球生物製藥塑膠市場規模：按應用領域分類

• 上游生物程序
• 下游生物程序
• 藥品儲存和包裝

全球生物製藥塑膠市場規模：依最終用戶分類

• 生物製藥公司
• CDMO
• 研究機構

全球生物製藥塑膠市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Sartorius AG
• Cytiva（Danaher）
• Thermo Fisher Scientific
• Merck KGaA
• Parker Hannifin
• Saint-Gobain（Tygon）
• Avantor Inc.
• Meissner Filtration Products
• Entegris Inc.
• Lonza Group
• Repligen Corporation
• Novatek International
• Corning Life Sciences
• Pall Corporation（Danaher）
• Genentech（Roche）

結論與建議

Global Biopharma Plastics Market size was valued at USD 22.52 Billion in 2024 and is poised to grow from USD 24.19 Billion in 2025 to USD 42.85 Billion by 2033, growing at a CAGR of 7.42% during the forecast period (2026-2033).

The global biopharma plastics market is witnessing significant growth propelled by the rising demand for single-use systems that enhance manufacturing flexibility and reduce contamination risks. Key applications in drug development, biologics manufacturing, and clinical supply are increasingly reliant on polymeric components, vital for ensuring sterility, scalability, and regulatory compliance-all critical for product safety and market readiness. The shift from stainless steel to disposable systems has given rise to lower capital expenditures and facilitated production capacity expansion. Moreover, the need for agile supply chains and stringent contamination controls is pushing manufacturers to adopt validated disposable products, streamlining processes and minimizing documentation burdens. Innovations like single-use bioreactor systems and pre-filled polymer syringes exemplify how advancements in materials and supplier capabilities are unlocking substantial growth opportunities and reducing costs in the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharma Plastics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharma Plastics Market Segments Analysis

Global biopharma plastics market is segmented by product type, material, application, end-user and region. Based on product type, the market is segmented into single-use bags, bioprocess containers, tubing & connectors and bottles & vials. Based on material, the market is segmented into polyethylene (PE), polypropylene (PP) and ethylene vinyl acetate (EVA). Based on application, the market is segmented into upstream bioprocessing, downstream bioprocessing and drug storage & packaging. Based on end-user, the market is segmented into biopharmaceutical companies, CDMOs and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharma Plastics Market

The global biopharma plastics market is primarily driven by stringent regulatory mandates and safety standards that necessitate the use of high-quality polymer materials in biopharmaceutical manufacturing. These materials are vital for minimizing contamination risks and ensuring the integrity of production processes. Consequently, there is a surge in demand for specialty plastics tailored for sterile single-use systems, which come with validated performance requirements. This demand has prompted manufacturers to broaden their product offerings and enhance quality assurance measures. The focus on regulatory compliance fosters long-term partnerships and encourages the adoption of purpose-built components, ultimately promoting industry growth by aligning practices with regulatory expectations and significantly reducing manufacturing variability.

Restraints in the Global Biopharma Plastics Market

The Global Biopharma Plastics market encounters significant challenges due to the concerns surrounding material compatibility, particularly regarding leachables and extractables. As a result, developers of biopharmaceuticals tend to exercise considerable caution, which in turn hinders the adoption of innovative polymer formulations within essential manufacturing processes. This need for thorough compatibility testing and comprehensive characterization protocols often results in organizations favoring established materials over potentially superior alternatives. Such risk-averse practices not only complicate the development of biopharmaceutical products but also prolong the timelines for qualifying both suppliers and materials, ultimately impacting the market's progression.

Market Trends of the Global Biopharma Plastics Market

The Global Biopharma Plastics market is witnessing a significant trend towards the expansion of single-use systems, driven by their capacity to enhance manufacturing efficiency and safety. As bioprocesses evolve to become more flexible and scalable, these systems mitigate the risk of cross-contamination while accelerating production timelines. Manufacturers and contract manufacturing organizations (CMOs) are increasingly seeking bespoke polymer assemblies, connectors, and aseptic components that facilitate rapid changeover without incurring substantial upfront investments. This trend has fostered collaborative development between plastic suppliers and end users, enabling a diversified and integrated supply chain designed for reliability and seamless compatibility with automated systems.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Biopharma Plastics Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Single-Use Bags
• Bioprocess Containers
• Tubing & Connectors
• Bottles & Vials

Global Biopharma Plastics Market Size by Material & CAGR (2026-2033)

• Market Overview
• Polyethylene (PE)
• Polypropylene (PP)
• Ethylene Vinyl Acetate (EVA)

Global Biopharma Plastics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Upstream Bioprocessing
• Downstream Bioprocessing
• Drug Storage & Packaging

Global Biopharma Plastics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical Companies
• CDMOs
• Research Institutes

Global Biopharma Plastics Market Size & CAGR (2026-2033)

• North America (Product Type, Material, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Material, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (Danaher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saint-Gobain (Tygon)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meissner Filtration Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Entegris Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Repligen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novatek International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pall Corporation (Danaher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (Roche)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations